Distal Deep Vein Thrombosis in a Patient Cured of Severe COVID-19 Pneumonia at Jimma, Oromia, Ethiopia 2021: A Rare Case Report

Background: Deep vein thrombosis (DVT) is commonly identified and diagnosed in the emergency department. Factors including sedentary life (immobility), pregnancy in women, cancer, postoperation, admission to ICU, smoking, and obesity are identified risks for thrombosis development. We report a case...

Full description

Saved in:
Bibliographic Details
Published in:International medical case reports journal 2021-08, Vol.14, p.519-522
Main Authors: Debela, Dejene, Sr, Ababulgu, Elias, Desu, Gaddisa, Abebe, Serkaddis, Adugna, Tesfaye
Format: Article
Language:English
Subjects:
antithrombotic drugs
Bacterial pneumonia
Blood clots
Case Report
Case reports
Coronaviruses
COVID-19
Diagnosis
Disease prevention
Enzymes
Hospital patients
Hospitals
hypercoagulability
Hypertension
Laparoscopy
Patients
Pneumonia
post-covid-19
Pulmonary embolisms
Risk assessment
Risk factors
Severe acute respiratory syndrome coronavirus 2
Thromboembolism
Thrombosis
Ultrasonic imaging
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Deep vein thrombosis (DVT) is commonly identified and diagnosed in the emergency department. Factors including sedentary life (immobility), pregnancy in women, cancer, postoperation, admission to ICU, smoking, and obesity are identified risks for thrombosis development. We report a case of a 35-year-old man who presented to the emergency department developing left lower leg swelling and pain, low-grade fever, and headache after he was treated and discharged, cured of severe COVID-19. Then venous and arterial Doppler ultrasound of the lower leg revealed dilated, absent flow and luminal thrombus in the distal popliteal, anterior and posterior tibial veins and perforator vessels were diagnosed as leg DVT. Conclusion: DVT is a hematological emergency that needs serious consideration in prevention as well early diagnosis in patients with possible risk factors. This case report aims to arouse the clinician's awareness of the occurrence of deep vein thrombosis during and after COVID-19. Keywords: post-COVID-19, thromboembolism, hypercoagulability, antithrombotic drugs
ISSN:1179-142X
1179-142X
DOI:10.2147/IMCRJ.S322301